Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
Clinical trial NCT02015169 · COMPLETED
Trial details
- NCT number
- NCT02015169
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-09
- Primary completion
- 2017-07-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.